Berlin, AstraZeneca reject reports on COVID jab efficacy in elderly
The EU has currently authorised two vaccines for widespread distribution, manufactured by BioNTech/Pfizer and Moderna.
Wed Jan 27 2021
AstraZeneca CEO expects to run new global trial of COVID-19 vaccine: Bloomberg
AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage.
Fri Nov 27 2020